UTI (Universal Technical Institute, Inc.) Stock Analysis - Insider Trades
Universal Technical Institute, Inc. (UTI) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, UTI trades at $36.83 with a market cap of $2.15B and a P/E ratio of 47.19. UTI moved +3.13% today. Year to date, UTI is +35.13%; over the trailing twelve months it is +4.78%. Its 52-week range spans $15.14 to $41.53. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces UTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading UTI stock inside the company?
Recent UTI insider activity includes SRERE LINDA J sold 15.00K, Kevane Christopher E. sold 23.65K, Brochick George W. sold 5.00K, Okinaka Shannon Lei sold 10.00K, and Hitchcock Todd A sold 16.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
UTI Key Metrics
Key financial metrics for UTI
Metric
Value
Price
$36.83
Market Cap
$2.15B
P/E Ratio
47.19
EPS
$0.78
Dividend Yield
0.02%
52-Week High
$41.53
52-Week Low
$15.14
Volume
4
Avg Volume
0
Revenue (TTM)
$868.99M
Net Income
$42.68M
Gross Margin
0.00%
Recent UTI Insider Trades
SRERE LINDA J sold 15.00K (~$548.80K) on May 11, 2026.
Kevane Christopher E. sold 23.65K (~$888.12K) on Mar 27, 2026.
Brochick George W. sold 5.00K (~$182.94K) on Mar 17, 2026.
Okinaka Shannon Lei sold 10.00K (~$347.41K) on Mar 6, 2026.
Hitchcock Todd A sold 16.50K (~$615.95K) on Mar 4, 2026.
Recent UTI insider activity includes SRERE LINDA J sold 15.00K, Kevane Christopher E. sold 23.65K, Brochick George W. sold 5.00K, Okinaka Shannon Lei sold 10.00K, and Hitchcock Todd A sold 16.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for UTI?
Yes. Rallies tracks UTI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is UTI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTI. It does not provide personalized investment advice.